Letter to the Editor
Bone Marrow Transplantation (2008) 42, 553–554; doi:10.1038/bmt.2008.200; published online 14 July 2008
Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT in the first CR
H Tamai1, H Yamaguchi1, S Takahashi2, A Tojo2, H Hamaguchi3, T Kobayashi4, H Akiyama4, H Sakamaki4, H Okumura5, Si Nakao5, A Arai6, O Miura6, K Tajika1, K Inokuchi1 and K Dan1
- 1Department of Hematology, Nippon Medical School, Tokyo, Japan
- 2Department of Hematology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- 3Department of Hematology, Musashino Red Cross Hospital, Tokyo, Japan
- 4Department of Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
- 5Department of Hematology, Kanazawa University, Ishikawa, Japan
- 6Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
Correspondence: H Tamai, E-mail: s6056@nms.ac.jp
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Current status of hematopoietic stem cell transplantations in Vietnam
Bone Marrow Transplantation Review
Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin
Bone Marrow Transplantation Review
Bone Marrow Transplantation Review
RESEARCH
Leukemia Letter
Bone Marrow Transplantation Original Article
